当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析

海翔药业

(002099)

  

流通市值:90.72亿  总市值:90.81亿
流通股本:16.17亿   总股本:16.19亿

海翔药业(002099)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.39亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益598445.72万元,未分配利润121009.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产849457.89万元,负债251012.17万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,676,630,297.771,196,440,659.01634,047,833.62,704,144,046.05
营业总成本1,659,118,871.861,133,067,681.29642,125,9352,476,304,932.39
营业利润-44,358,035.4417,897,795.9844,299,883.65109,398,963.01
利润总额-45,728,314.2917,046,946.9244,070,550.66100,803,110.15
净利润-39,479,339.5118,438,691.2341,848,946.586,078,081.06
其他综合收益---4,223,614.22
综合收益总额-39,479,339.5118,438,691.2341,848,946.590,301,695.28
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计3,475,692,833.673,676,867,789.214,027,776,667.23,245,690,461.75
非流动资产合计5,018,886,107.985,023,016,093.485,031,020,806.135,147,409,308.49
资产总计8,494,578,941.658,699,883,882.699,058,797,473.338,393,099,770.24
流动负债合计2,322,787,671.532,469,314,897.112,729,425,923.651,970,676,899.34
非流动负债合计187,334,075.06188,193,759.78182,607,805.96317,508,073.68
负债合计2,510,121,746.592,657,508,656.892,912,033,729.612,288,184,973.02
归属于母公司股东权益合计5,988,454,824.876,046,214,758.876,150,080,587.846,107,978,641.23
股东权益合计5,984,457,195.066,042,375,225.86,146,763,743.726,104,914,797.22
负债和股东权益合计8,494,578,941.658,699,883,882.699,058,797,473.338,393,099,770.24
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,615,487,174.661,061,288,219.59497,507,810.562,512,818,932.03
经营活动现金流出小计1,368,150,195.47951,798,792.67338,056,505.812,396,726,893.26
经营活动产生的现金流量净额247,336,979.19109,489,426.92159,451,304.75116,092,038.77
投资活动现金流入小计145,211,433.74141,064,033.74137,682,583.74648,753,928.04
投资活动现金流出小计278,564,270.27149,306,170.9355,996,620.91,269,070,119.6
投资活动产生的现金流量净额-133,352,836.53-8,242,137.1981,685,962.84-620,316,191.56
筹资活动现金流入小计2,167,210,2201,334,157,300966,107,4882,228,408,339.4
筹资活动现金流出小计1,704,609,980.02886,236,357.92362,399,978.712,350,290,471.02
筹资活动产生的现金流量净额462,600,239.98447,920,942.08603,707,509.29-121,882,131.62
汇率变动对现金及现金等价物的影响27,705,153.6923,617,578.54-12,080,904.4975,132,996.71
现金及现金等价物净增加额604,289,536.33572,785,810.35832,763,872.39-550,973,287.7
期末现金及现金等价物余额1,641,324,262.761,609,820,536.781,869,798,598.821,037,034,726.43
TOP↑